D. DYE: Open Payments
NPI 1437192903 · PURCELL, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,702 in 94 payments from 16 companies in 2025. Trend: 2023 $1,624 · 2024 $1,776 · 2025 $1,702
Food & beverage: $1,702
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $381 |
| PFIZER INC. | 21 | $306 |
| AstraZeneca Pharmaceuticals LP | 11 | $220 |
| Lilly USA, LLC | 10 | $169 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $98 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $89 |
| Amgen Inc. | 4 | $80 |
| Sumitomo Pharma America, Inc. | 4 | $77 |
| Teva Pharmaceuticals USA, Inc. | 4 | $72 |
| ABBVIE INC. | 3 | $51 |
Products named: Rybelsus, ELIQUIS, Ozempic, JARDIANCE, MOUNJARO, FARXIGA, Saxenda, NURTEC ODT.
Industry payments across OK — which companies pay providers there.
